European stocks shrug off coronavirus fears
European shares on Friday shrugged off worries over the coronavirus outbreak after the World Health Organisation designated it an emergency for China but not yet for the rest of the world.
Bayer Shares up 2.3% on report about possible glyphosate settlement
Shares in seeds and pesticides maker Bayer opened 2.3% higher on Friday, driven by a report on a possible out-of-court settlement of a U.S. jury trial over allegations that its weed killer Roundup causes cancer.
Euro near seven-week lows before PMI data release
The euro held near seven-week lows on Friday after the European Central Bank struck a more dovish tone at Thursday’s meeting than some had expected.
Italy watchdog launches non-compliance proceedings against Facebook
Italy’s competition watchdog has launched proceedings against Facebook for non-compliance with a previous request it had made regarding improper commercial practices in the group’s treatment of user data, the agency said on Friday.
Oil rises, but potential impact of China virus on fuel demand haunts market
Oil prices climbed on Friday, following a drawdown in U.S. crude stocks, but were set to fall heavily for the week amid worries that a new coronavirus in China that has killed 25 so far may spread, curbing travel, fuel demand and economic prospects.
Nestle teams up with Canadian plant-based ingredients makers
Food group Nestle has teamed up with Canadian plant-based food ingredient makers Burcon and Merit to speed up innovation in the fast-growing business segment, it said on Friday.
Stocks hold steady but virus anxiety lingers as millions travel for Lunar New Year break
Asian shares steadied on Friday in holiday-thinned trade for the Lunar New Year, despite fears that a new coronavirus from China could spread rapidly as millions of people travel over the week-long break.
Ericsson fourth-quarter core profit hit by slowdown in U.S. business, higher costs
Swedish telecoms equipment group Ericsson reported a smaller than expected rise in fourth-quarter core earnings on Friday and said the quarter, seasonally its best, had nevertheless been hit by a slowdown in its previously surging U.S. business and hi…
Bayer faces fourth U.S. Roundup cancer trial in Monsanto home court
Bayer AG is set to face a fourth U.S. jury trial over allegations that its popular weed killer Roundup causes cancer, with four cancer patients in the hometown of its agricultural subsidiary Monsanto scheduled to make their case beginning on Friday.
Shares in Bayer up 6.3% in premarket on report about possible glyphosate settlement
Shares in Bayer were up 6.3% in premarket trade at broker Lang & Schwarz on Friday, driven by a report on a possible out of court settlement of a U.S. jury trial over allegations that its weed killer Roundup causes cancer.
